At first, hypotension makes the HF treatment limited when it comes to administration of angiotensin receptor–neprilysin inhibitors, angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers, and beta‐blockers: at discharge, such patients may not have an optimized therapy, leading to a worse long‐term outcome. Here, MME is linked to hydrops fetalis.